electronRx to unveil digital monitoring smartphone tech at CES 2024

electronRx is set to introduce groundbreaking patient health monitoring technology for smartphones during CES 2024 in Las Vegas. The foneDx technology, designed to work with mobile phones, offers a scalable solution for monitoring pulmonary and cardiovascular health. By utilizing sensors already present in smartphones and a customized user interface app, it aims to revolutionize digital monitoring in the healthcare industry. This innovative solution, touted as the first of its kind, can be utilized by patients, healthcare providers, and commercial organizations to measure critical heart and lung health from the comfort of one’s home. CEO Bipin Patel envisions this technology as a game-changer, democratizing and scaling smartphone technology to improve millions of lives through better condition management and life-saving clinical outcomes. Real-time data capture will provide invaluable insights for healthcare professionals, and attendees at CES 2024 will have the opportunity to experience the potential of foneDx firsthand.